+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Marketing Authorization"

EU Pharmaceutical Regulations and Strategy (October 4-5, 2027) - Product Thumbnail Image

EU Pharmaceutical Regulations and Strategy (October 4-5, 2027)

  • Training
  • October 2027
  • 2 Days
  • Europe
EU Pharmaceutical Regulations and Strategy (March 1-2, 2027) - Product Thumbnail Image

EU Pharmaceutical Regulations and Strategy (March 1-2, 2027)

  • Training
  • March 2027
  • 2 Days
  • Europe
EU Pharmaceutical Regulations and Strategy (October 5-6, 2026) - Product Thumbnail Image

EU Pharmaceutical Regulations and Strategy (October 5-6, 2026)

  • Training
  • October 2026
  • 2 Days
  • Europe
From
From
From
From
Orphan Drug Growth Opportunities - Product Thumbnail Image

Orphan Drug Growth Opportunities

  • Report
  • March 2024
  • 78 Pages
  • Global
From
From
Latest Trends in Orphan Drug Pricing and Reimbursement - Product Thumbnail Image

Latest Trends in Orphan Drug Pricing and Reimbursement

  • Report
  • February 2018
  • 135 Pages
  • Global
From
From
From
From
From
From
A Journal of Drug Formulation, Development and Production - Product Thumbnail Image

A Journal of Drug Formulation, Development and Production

  • Journal Icon Journal
  • August 2026
  • 60 Pages
  • Global
From
From
Loading Indicator

The Marketing Authorization market is a key component of the Drug Discovery process. It is the process of obtaining approval from regulatory authorities to market a drug or medical device. This process involves submitting a dossier of data to the relevant regulatory body, which is then reviewed to ensure the product meets safety and efficacy standards. The dossier includes pre-clinical and clinical data, manufacturing information, and other relevant information. The process also includes post-marketing surveillance to ensure the product continues to meet safety and efficacy standards. Companies in the Marketing Authorization market include AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more